Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Irina Savelieva(St George's, University of London), Jens Cosedis Nielsen(Aarhus University), Ben Freedman(Heart Rhythm Society), Karl Georg Hæusler(Universitätsklinikum Würzburg), Davíð O. Arnar(University of Iceland), M. Oeff(Universitätsklinikum Brandenburg an der Havel), Deirdre A. Lane(University of Liverpool), A. John Camm(St George's, University of London), Doreen Haase(Atrial Fibrillation NETwork), Stefan Kääb(German Centre for Cardiovascular Research), Anders Ahlsson(Örebro University Hospital), Jeroen Hendriks, Hein Heidbüchel(University of Antwerp), Eduard Guasch(Centro de Investigación en Red en Enfermedades Cardiovasculares), Carina Blomström‐Lundqvist(Örebro University), Hugh Calkins(Johns Hopkins University), Dobromir Dobrev(University of Duisburg-Essen), Andreas Goette(Otto-von-Guericke University Magdeburg), Günter Breithardt(University Hospital Münster), Gregory Y.H. Lip(Medical University of Białystok), Axel Brandes(Odense University Hospital), Ulrich Schotten(Maastricht University), Jeroen J. Bax(Leiden University), Larissa Fabritz(University of Birmingham), Lluı́s Mont(Hospital Clínic de Barcelona), Isabelle Richard‐Lordereau(Amgen (Switzerland)), Manuel Castellà(Universitat de Barcelona), Michiel Rienstra(University Medical Center Groningen), Ali̇ Oto(Memorial Ankara Hospital), Angelo Auricchio(Ente Ospedaliero Cantonale), Barbara Casadei(John Radcliffe Hospital), Stefanie Kespohl(Bayer (Germany)), Tatjana Potpara(University of Belgrade), Thorsten Lewalter(München Klinik), Dan Atar, Ulf Landmesser(Deutsches Herzzentrum der Charité), Jonas Oldgren(Uppsala University), Ursula Ravens(University of Freiburg), Michael Näbauer(Ludwig-Maximilians-Universität München), Winnie Chua(University of Birmingham), Martin Feuring(Boehringer Ingelheim (Germany)), Harry J.G.M. Crijns(University Medical Center), Stefano Benussi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Andrea Gerth(Harvard University), Martin Borggrefe(Heidelberg University), Laurent Pison(Maastricht University), Craig Hunter(Boehringer Ingelheim (Germany)), Giuseppe Boriani(University of Modena and Reggio Emilia), Stéphane Hatem(Fondation pour l’innovation en Cadiométabolisme et Nutrition)
Cited by 115
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Worldwide Epidemiology of Atrial Fibrillation
|Circulation|2013|4.5k